Novel Drug Delivery Systems: An Overview

Authors

  • Sameeksha Jain Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001
  • Meena Kirar Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001
  • Mahima Bindeliya Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001
  • Lucky Sen Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001
  • Madhur Soni Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001
  • Md Shan Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001
  • Arpana Purohit Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001
  • Prateek Kumar Jain Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

DOI:

https://doi.org/10.22270/ajdhs.v2i1.14

Keywords:

Novel drug delivery system, Conventional drug delivery, Pharmaceutical companies, Pharmacokinetics

Abstract

The performance of an existing medicinal molecule in terms of patient compliance, safety, and efficacy can be greatly enhanced by evolving it from a traditional form to a unique delivery mechanism. An old medication molecule can be given new life as a Novel Drug Delivery System. The limitations of the conventional drug delivery methods are addressed by the innovative drug delivery system, which is a novel method of drug administration. A significant improvement in the ability to release a drug at a specified spot and rate is possible with a novel drug delivery system that is properly developed. Pharmaceutical companies are working to create novel drug delivery systems in order to give medications to patients effectively and with fewer side effects. The fundamentals of novel drug delivery systems, as well as their various varieties, are covered in this article. The scientific requirements to be incorporated in novel drug delivery systems, such as nanoparticles, microemulsions, matrix systems, solid dispersions, liposomes, solid lipid nanoparticles, and so on, can be met by modern phytopharmaceuticals research, though, by determining pharmacokinetics, mechanism of action, site of action, required precise dose, etc.

Keywords: Novel drug delivery system, Conventional drug delivery, Pharmaceutical companies, Pharmacokinetics.

Author Biographies

Sameeksha Jain, Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Meena Kirar, Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Mahima Bindeliya, Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Lucky Sen, Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Madhur Soni, Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Md Shan, Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Arpana Purohit, Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Prateek Kumar Jain, Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

Adina College of Pharmacy, ADINA Campus Rd, Lahdara, Sagar, MP, 470001

References

Reddy PD, Swarnalatha D. Recent advances in novel drug delivery systems. Int J PharmTech Res., 2010; 2(3):2025-2027.

Muller CC. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm., 2004; 58(2):343-356. https://doi.org/10.1016/j.ejpb.2004.03.028

http://www.azonano.com/oars.asp

Sharma A, Sharma US. Liposomes in drug delivery: Progress and limitations. Int J Pharm., 1997; 154(2):123-140. https://doi.org/10.1016/S0378-5173(97)00135-X

Lau JR, Geho WB, Snedekar GH. Inventors; SDG INC, An Ohio Corporation, Assignee; Targeted Liposomal Drug Delivery System. US Patent 20100209492. 2010 Aug 19.

Takagi A, Yamashita N, Sonobe T. Inventors; Astellas Pharma INC Tokyo, Assignee; Intracellular Drug Delivery Improving Liposomes. US Patent 20070286898. 2007 Dec 13.

Lau JR,Geho WB, Snedekar GH. Inventors; Targeted Liposomal Drug Delivery System. US Patent 20070104777. 2007 May 10.

Zhang Y, Luo B, Iyer L. Inventors; Liposomal Delivery Vehicle for Hydrophobic Drugs. US Patent 20070014845. 2007 Jan 18.

Yamauchi H, Morita H, Kikuchi H. Inventors; Daiichi pharmaceuticals Co.LTD, Assignee; Liposomes And Liposomal Dispersion. US Patent 20020182248. 2002 Dec 5.

Verma RK, Garg S, Current status of drug delivery technologies and future directions. Pharm Tech On-Line. 2001; 25(2):1-14.

Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001; 73:137-72. https://doi.org/10.1016/S0168-3659(01)00299-1

Turos E, Cormier R, Kyle DE. Inventors; University of South Florida FL, Assignee; Polyacrylate Nanoparticle Drug Delivery. US Patent 20100278920. 2010 Nov 4.

Sung H, liang H, Tu H. Inventors; Nanoparticle For Protein Drug Delivery. US Patent 20090155374. 2009 June 18.

Jacobson GB, Zare RN, Markides KE, Shinde RR. Inventors; Encasulated Nanoparticle For Drug Delivery. US Patent 20080095856. 2008 Apr 24.

Lobl TJ, Schloss JV, Nagy AI, Pananen JE. Inventors; Neurosystec corporation, Valencia CA, Assignee; Nanoparticle Drug Formulation. US Patent 20080145439. 2008 June 19.

Singh AN, Mahanti B, Bera K. Novel Drug Delivery System & It's Future: An Overview. Int J Pharm Engin., 2021; 9(2):1070-1088.

Wu D, Chu CC, Carozza J. Inventors. Injectable Microspheres. US Patent 20110151004. 2011 June 23.

Sah HK, Inventor; SK Chemicals CO LTD KR. Assignee; Method For Producing Microspheres Loaded with Drugs And Microspheres Loaded With Drugs Produced Thereby. US Patent 20090318569. 2009 Dec 24.

Shah S. Novel drug delivery carrier: Resealed erythrocytes, Int J Pharma Biosci., 2011; 2(1):394-406.

Raut D, Sakhare R, Dadge K, Halle PD. Resealed erythrocytes drug delivery: A Review, Int J Pharm Chem., 2013; 2:193-205.

Gupta A, Mishra AK, Bansal P, Kumar S, Gupta V, Singh R, Kalyan GS. Cell based drug delivery system through resealed erythrocyte-a review. Int J Pharm Sci Drug Res., 2010; 2(1):23-30

Magnani M, Rossi L, Biagiotti S, Bioanchi M. Inventors; Drug Delivery System. US Patent 20120141540. 2012 June 7.

Grimald S, Lisi A, Cinti C. Inventors; CNR Conciglio Nazionale Delle Ricerche Roma, Assignee; US Patent 20110262415. 2011 Oct 27.

Yang VC, Kwon YM, Chung HS, Yang AJ. Inventors; Erythrocyte encapsulated L- aspaginase for enhanced acute Lymphoblastic Leukemia Therapy. US Patent 20100284982. 2010 Nov 11.

Madhar NVS, Saini A. Niosomes: A novel drug delivery system. Int J Res Pharm Chem., 2011; 1(3):498-511.

Alcantor N, Williams EC, Toomey R. Inventors; University of South florida,FL, Assignee; Niosome Hydrogel Drug Delivery Systems. US Patemt 20100068264. 2010 Mar 18.

Arunachalam A, Karthikeyan M, Vinay Kumar D. et al., Transdermal drug delivery system: a review. Curr Pharm Res., 2010; 1(1):70-81. https://doi.org/10.33786/JCPR.2010.v01i01.015

Sharma B, Saroha K, Yadav B. Sonophoresis: An advanced tool in transdermal drug delivery system. Int J Curr Pharm Res., 2011; 3(3):89-97.

Easterbrook TJ, Gosden E, Meyer E. Inventors; Transdermal Drug Delivery device. US Patent 20110190716. 2011 Aug 4.

Tang J. Inventor; Stabilised Transdermal Drug Delivery System. US Patent 20110182949. 2011 July 28.

Nisato G, Baret JC. Inventors; Koninklijke Philips Electronics N.V, NC, Assignee; Transdermal Drug Delivery Patch. US Patent 20100222751. 2010 June 10.

Heiati H, Weimann L. Inventor; Pharmapatch LLC, San Diego CA, Assignee; Multiple Nozzle Transdermal Drug Delivery System. US Patent 20100143448. 2010 Sept 2.

Vinod KR, Reddy R, Banji D, Reddy V, Sandhya S. Critical review on mucoadhesive drug delivery systems. Hygeia J Drugs Med., 2012; 6(1):7-28.

Yoon HJ, Jang WD. Polymeric supramolecular systems for drug delivery. J Mater Chem., 2010; 2:211-222. https://doi.org/10.1039/B910948J

Zerbe HG, Paiement N. Inventor; Oral Mucoadhesive Dosage form. US Patent 20110028431. 2011 Feb 3.

Sambasivam M. Inventor; Convatec Technologies INC, NV, Assignee; Ostomy Devices With Mucoadhesives. US Patent 2010010064. 2010 Apr 22.

David AE, Zhang R, Park YJ, Yang AJM, Yang VC. Inventors; Mucoadhesive Vescicles For Drug Delivery. US Patent 20090232899. 2009 Sept 17.

Gupta S, Singh RP, Sharma R, Kalyanwat R, Lokwani P. Osmotic pumps: A Review. Int J Comprehen Pharm., 2011; 6(1):1-8.

Patel H, Patel U, Kadikar H, Bhimani B, Daslaniya D, Patel G. A review on osmotic drug delivery system. Int Res J Pharm., 2012; 3(4):88-94.

Nghiem T, Jackson G. Inventors; Biovail Laboratories International S.R.L., Assignee; Multiparticulate Osmotic Delivery System. US Patent 20090004281. 2009 Jan 1.

Patel HB. Inventor; Reliant pharmaceuticals INC., Assignee; Oral Osmotic Drug Delivery System. US Patent 20080248114. 2008 Oct 9.

Kidane A, Bhatt PP. Inventors; Osmotic Drug Delivery System. US Patent 20070254032. 2007 Nov 1.

Kumar A, Sharma P, Banik A. Microencapsulation as novel drug delivery system. Int Pharm Sci., 2011; 1(1):1-7.

Saraf AS. Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010; 81:680-689. https://doi.org/10.1016/j.fitote.2010.05.001

He ZF, Liu DY, Zeng S, Ye JT. Study on preparation of ampelopsin liposomes. J Chine Mat Med., 2008; 33(1):27-30.

Rane S, Prabhakar B. Influence of liposome composition on paclitaxel entrapment & pH sensitivity of liposomes. Indian J Phys Ther Res., 2009; 1(3):914-917.

Godin B, Touitou E. Mechanism of bacitricin permeation enhancement through the skin & cellular membrane from an ethosomal carrier. J Control Release. 2004; 94(2-3):365-379. https://doi.org/10.1016/j.jconrel.2003.10.014

Youfang C, Xianfu L, Hyunjin P, Richard G. Artemisnin nanoparticles. Nanomed Nanotechnol Biol Med., 2009; 5:316-322.

Shimada S. Composition comprising nanoparticle Ginkgo biloba extract with the effect of brain function activation. US Patent 8105637; 2012 Jan 31.

Bhattacharya S. Phytosomes: Emerging strategy in delivery of herbal drugs & nutraceuticals. Pharma Times. 2009; 41(3):9-12.

Wu JH, Yen FL, Lin LT, Tsai TR, Lin CC, et al., Preparation, physicochemical characterization & antioxidant effects of quercetin nanoparticle. Int J Pharm.. 2008; 346:160-168. https://doi.org/10.1016/j.ijpharm.2007.06.036

Sampath Kumar KP, Bhowmik D, Chiranji B, Chandira M, Tripathi KK. Innovations in sustained release drug delivery system and its market opportunities. J Chem Pharm Res., 2010; 2(1):349-360

Published

15.03.2022

How to Cite

Jain, S. ., Kirar, M. ., Bindeliya, M. ., Sen, L. ., Soni, M. ., Shan, M. ., Purohit, A. ., & Jain, P. K. . (2022). Novel Drug Delivery Systems: An Overview. Asian Journal of Dental and Health Sciences, 2(1), 33–39. https://doi.org/10.22270/ajdhs.v2i1.14

Citations

Most read articles by the same author(s)

1 2 > >>